CTGF Composition for diagnosing polycystic kidney disease comprising agent for detecting CTGF and use thereof

• 1. 嵌合蛋白、其生产方法和用途，以及核酸分子、表达盒、表达载体、宿主细胞、用于诊断利什曼病的组合物、用于诊断利什曼病的试剂盒和体外诊断利什曼病的方法 [P] . 中国专利： CN113784975A . 2021-12-10
• 2. 一种用于宫颈癌诊断的肿瘤诊断组合物和用于制备诊断试剂盒的用途 [P] . 中国专利： CN107677825B . 2019.04.23
• 3. Composition for diagnosing polycystic kidney disease comprising agent for detecting CTGF and use thereof [P] . KR102288447B1 . 2021-08-10

  机译： 用于诊断多囊肾疾病的组合物包含用于检测CTGF的药剂及其用途

• 4. Composition for diagnosing polycystic kidney disease comprising agent for detecting CTGF and use thereof [P] . 韩国专利： KR1020200083344A . 2020.07.08
• 5. Composition for diagnosing polycystic kidney disease comprising agent for detecting DNM1 and use thereof [P] . KR20220005352A . 2022-01-13

  机译： 用于诊断多囊肾疾病的组合物包含用于检测DNM1的药剂及其用途

• 1. SHIP, a novel factor to ameliorate extracellular matrix accumulation via suppressing PI3K/Akt/CTGF signaling in diabetic kidney disease [J] . Li Fan, Li Lisha, Cheng Meijuan, Biochemical and Biophysical Research Communications . 2017,第4期
• 2. Targeting CTGF, EGF and PDGF pathways to prevent progression of kidney disease [J] . KokH.M., FalkeL.L., GoldschmedingR., Nature reviews. Nephrology . 2014,第12期
• 3. CTGF siRNA ameliorates tubular cell apoptosis and tubulointerstitial fibrosis in obstructed mouse kidneys in a Sirt1-independent manner [J] . Yunzhuo Ren, Chunyang Du, Li Yan, Drug Design, Development and Therapy . 2015,第4期
• 4. Detection and Segmentation of Kidneys from Magnetic Resonance Images in Patients with Autosomal Dominant Polycystic Kidney Disease [C] . Antonio Brunetti, Giacomo Donato Cascarano, Irio De Feudis, International conference on intelligent computing . 2019
• 5. Kidney segmentat ion and image analysis in autosomal dominant polycystic kidney disease [D] . Warner, Joshua Dale. 2016
• 6. CTGF Is Expressed During Cystic Remodeling in the PKD/Mhm (cy/+) Rat Model for Autosomal-Dominant Polycystic Kidney Disease (ADPKD) [O] . Stefan Gauer, Yvonne Holzmann, Bettina Kränzlin, 2017
• 7. CTGF Is Expressed During Cystic Remodeling in the PKD/Mhm (cy/+) Rat Model for Autosomal-Dominant Polycystic Kidney Disease (ADPKD) [O] . Stefan Gauer, Yvonne Holzmann, Bettina Kränzlin, 2017

• 1. Tesevatinib ameliorates progression of polycystic kidney disease in rodent models of autosomal recessive polycystic kidney disease [J] . William E Sweeney ,Philip Frost ,Ellis D Avner . 世界肾病学杂志：英文版 . 2017,第4期
• 2. Autosomal dominant polycystic liver disease in a family without polycystic kidney disease associated with a novel missense protein kinase C substrate 80K-H mutation [J] . Ramón Peces ,Joost PH Drenth ,Rene HM te Morsche . 世界胃肠病学杂志：英文版 . 2005,第48期
• 3. A successful case of combined liver and kidney transplantation for autosomal dominant polycystic liver and kidney disease [J] . HE Xiao Shun HUANG Jie Fu CHEN Gui Hua ZHENG Ke Li and YE Xiao Ming . 世界胃肠病学杂志：英文版 . 1999,第1期
• 4. Spontaneous coronary dissection should not be ignored in patients with chest pain in autosomal dominant polycystic kidney disease:A case report [J] . Jun Qian ,Yan Lai ,Li-Jun Kuang . 世界临床病例杂志 . 2021,第013期
• 5. Successful endoscopic surgery for emphysematous pyelonephritis in a non-diabetic patient with autosomal dominant polycystic kidney disease: A case report [J] . Yi Jiang ,Richard Lo ,Zhen-Quan Lu . 世界临床病例杂志 . 2021,第012期
• 6. 甘草酸18α体调节梗阻性肾病大鼠肾间质中CTGF和TGF-β1表达的实验研究 [C] . 李开龙 ,张建国 ,王慧民 . 中华医学会肾脏病及血液净化诊治新进展学术研讨会 . 2004
• 7. 前列腺素E对梗阻性肾病中TGF-β和CTGF表达的影响的实验研究 [A] . 牛晓华 . 2006